Roche’s Genentech Doubles North Carolina Facility Investment to About $2 Billion
Genentech, a unit of Roche, said it will more than double its planned investment in a biomanufacturing facility in North Carolina to about $2 billion, reinforcing its commitment to expanding production in the United States. The facility, located in Holly Springs, North Carolina, is expected to become operational by 2029 and will focus on manufacturing […]
